Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 56.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement to 31 March 2014

19 May 2014 14:21

RNS Number : 4863H
British Smaller Companies VCT2 Plc
19 May 2014
 



 

British Smaller Companies VCT2 plc

Interim Management Statement

For the quarter ended 31 March 2014

British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 31 March 2014. The statement also includes relevant financial information between the end of the quarter and the date of this statement. This constitutes the Company's first interim management statement for the financial year ending 31 December 2014, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfmep.com.

Performance

The total return at 31 March 2014, calculated by reference to the Net Asset Value (NAV) per ordinary share and the cumulative dividends paid per ordinary share, was 105.3 pence per ordinary share compared to 104.6 pence per ordinary share at 31 December 2013. Cumulative dividends represent 39.0 pence per ordinary share (31 December 2013: 39.0 pence per ordinary share).

The unaudited NAV per ordinary share as at 31 March 2014 was 66.3 pence (31 December 2013: 65.6 pence per ordinary share) representing an increase of 0.7 pence per ordinary share. The increase in NAV per ordinary share is principally due to the net upward movement, in both the AIM quoted and unquoted portfolio valuations.

The number of ordinary shares in issue at 31 March 2014 was 57,923,961 (31 December 2013: 46,443,563). In addition, at 31 March 2014, the Company held 1,777,722 ordinary shares in treasury (31 December 2013: 1,777,722).

Share Issues

During the period the Company has issued 11,480,398 ordinary shares between 68.00 to 71.19 pence per share, pursuant to the Company's joint offer for Subscription with British Smaller Companies VCT plc.

Net assets at 31 March 2014 comprised the following:

£000

% of net assets

Unquoted investments at fair value

15,084

39.29

Quoted investments at bid price

2,575

6.71

Gilt investments

890

2.31

Total investments

18,549

48.31

Cash and cash equivalents

15,349

39.98

Cash on fixed term deposit

4,500

11.72

Other net current assets

(4)

(0.01)

Net assets

38,394

100.00

 

The investment portfolio at 31 March 2014 was comprised as follows:

Valuation

£000

Valuation as a % of net assets

DisplayPlan Holdings Limited

2,075

5.40

Gill Marine Holdings Limited

1,870

4.87

Mangar Health Limited

1,640

4.27

Seven Technologies Holdings Limited

1,628

4.24

GTK (UK) Limited

1,113

2.90

Immunobiology Limited

987

2.57

Leengate Holdings Limited

934

2.43

Deep-Secure Ltd

875

2.28

Callstream Group Limited

751

1.96

Pressure Technologies plc

682

1.78

12,555

32.70

Other investments

5,104

13.29

Gilt investments

890

2.32

Total investments

18,549

48.31

 

During the three months ended 31 March 2014 the Company made two investments totalling £1.70 million. These comprised one new investment of £1.64 million into Mangar Health Limited, a world leader in inflatable lifting, handling and bathing equipment for the elderly, disabled and emergency services markets, and £0.06 million of follow- on investment into EKF Diagnostics plc.

In the 3 months to 31 March 2014 cash proceeds of £0.31 million were received relating to the repayment of capital from the Company's loan portfolio, including £0.05 million of redemption premiums following the early repayment of capital by DisplayPlan Holdings Limited. In addition the Company received £0.35 million from the sale of shares from its AIM quoted investment portfolio. In total these disposals generated a profit on the previous quarter's carrying value of £0.05 million.

Since the end of the quarter the Company has completed one further investment of £1.96 million into Intelligent Office Limited, a global provider and manufacturer of electronic solutions. In addition it has approved, but not yet completed, a further two investments totalling £1.55 million.

 

Portfolio Performance

Over the 3 months to 31 March 2014 the portfolio saw an overall increase in unrealised valuations of £0.30 million. This comprised an increase in the value of a number of portfolio companies following strong trading results including Pressure Technologies plc (up £0.25 million), DisplayPlan Holdings Limited (up £0.16 million), and Callstream Group Limited (up £0.11 million) together with resilient performances across much of the Company's remaining unquoted and AIM portfolio.

The Board continues to follow a policy of maintaining a diversified portfolio: as at 31 March 2014 there was only one investment representing more than 5 per cent each of the NAV of the Company.

 

Outlook

The Board believes that the current economic climate continues to create investment opportunities in the short to medium term in well managed UK businesses that need capital to expand. Following the increase in the investment limit applying to venture capital trusts to £5 million per investment in any one year there has been an increase in the number of investment opportunities presented to the Company. Since the period end the Company has completed and approved investments of £3.51 million..

 

19 May 2014

 

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 294 5039

Matt Thomas N+1 Singer Tel: 0207 496 3000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLLFLVEVIALIS
Date   Source Headline
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.